Pfizer and BioNTech will examine how well the modified COVID vaccine works on three groups: people who are unvaccinated, fully vaccinated, and fully vaccinated and boosted Pfizer and BioNTech have ...
Pfizer and BioNTech announced on Tuesday that the companies will start a human trial to evaluate the efficacy, safety, and tolerability of a vaccine specifically modified to target the omicron variant ...
Pfizer and BioNTech said Friday that the immune responses against Omicron BA.4/BA.5 subvariants were “substantially higher” in people who got its new bivalent booster compared with people who received ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback